Trade Summary

Yesterday, snyderman nancy lynn MD, serving as Dir at Alkermes plc. (ALKS), sold 44,472 shares at $50.35 per share, for a total transaction value of $2,239,076.26. Following this transaction, snyderman nancy lynn MD now holds 15,395 shares of ALKS.

This sale represents a 74.28% decrease in snyderman nancy lynn MD's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 3, 2026 at 7:16 PM ET, meaning the disclosure happened on the same day as the trade.

Alkermes plc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.